Generic Pills Allowed Limited Size Differential In Draft Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA cites concern about safety and patient adherence to therapy in draft guidance on the size, shape and other physical attributes of generic drugs.